دورية أكاديمية
Antiretroviral Drugs Impact Autophagy with Toxic Outcomes.
العنوان: | Antiretroviral Drugs Impact Autophagy with Toxic Outcomes. |
---|---|
المؤلفون: | Cheney L; Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA., Barbaro JM; Department of Pathology, Montefiore Medical Center and Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA., Berman JW; Department of Pathology, Montefiore Medical Center and Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.; Department of Microbiology and Immunology, Montefiore Medical Center and Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA. |
المصدر: | Cells [Cells] 2021 Apr 15; Vol. 10 (4). Date of Electronic Publication: 2021 Apr 15. |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Review |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI |
مواضيع طبية MeSH: | Anti-Retroviral Agents/*toxicity , Autophagy/*drug effects, Animals ; Drug Therapy, Combination ; HIV/drug effects ; Humans ; Protease Inhibitors/pharmacology ; Reverse Transcriptase Inhibitors/pharmacology |
مستخلص: | Antiretroviral drugs have dramatically improved the morbidity and mortality of people living with HIV (PLWH). While current antiretroviral therapy (ART) regimens are generally well-tolerated, risks for side effects and toxicity remain as PLWH must take life-long medications. Antiretroviral drugs impact autophagy, an intracellular proteolytic process that eliminates debris and foreign material, provides nutrients for metabolism, and performs quality control to maintain cell homeostasis. Toxicity and adverse events associated with antiretrovirals may be due, in part, to their impacts on autophagy. A more complete understanding of the effects on autophagy is essential for developing antiretroviral drugs with decreased off target effects, meaning those unrelated to viral suppression, to minimize toxicity for PLWH. This review summarizes the findings and highlights the gaps in our knowledge of the impacts of antiretroviral drugs on autophagy. |
References: | J Antimicrob Chemother. 2014 Nov;69(11):2995-3000. (PMID: 25011651) Drugs. 2009 May 29;69(8):1107-40. (PMID: 19496633) AIDS. 2018 Jul 31;32(12):1579-1587. (PMID: 29734217) J Clin Endocrinol Metab. 2014 May;99(5):E734-45. (PMID: 24483157) J Neurovirol. 2019 Apr;25(2):263-274. (PMID: 30746609) Curr HIV Res. 2010 Mar;8(2):127-33. (PMID: 20163345) Antimicrob Agents Chemother. 2015 Oct 19;60(1):168-79. (PMID: 26482305) Antimicrob Agents Chemother. 2013 Jan;57(1):543-51. (PMID: 23147731) J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):423-431. (PMID: 27984559) Front Neurol. 2020 Sep 04;11:840. (PMID: 33013619) Br J Clin Pharmacol. 2006 Feb;61(2):148-54. (PMID: 16433869) J Cancer. 2018 Jan 1;9(1):117-128. (PMID: 29290776) Int J Mol Sci. 2017 Apr 08;18(4):. (PMID: 28397763) Cell. 2011 Sep 2;146(5):682-95. (PMID: 21884931) Antivir Ther. 2008;13(6):833-8. (PMID: 18839784) Int J Mol Sci. 2021 Jan 12;22(2):. (PMID: 33445576) J Pharm Pract. 2011 Apr;24(2):216-22. (PMID: 21712217) Clin Infect Dis. 2020 Jun 20;:. (PMID: 32564058) J Exp Clin Cancer Res. 2016 Jun 17;35(1):94. (PMID: 27317342) J Infect Dis. 1999 Sep;180(3):862-4. (PMID: 10438381) N Engl J Med. 1999 Dec 16;341(25):1865-73. (PMID: 10601505) Cancer Lett. 2020 May 28;478:133-145. (PMID: 32112906) Antimicrob Agents Chemother. 2018 Dec 21;63(1):. (PMID: 30373793) Mol Oncol. 2015 Mar;9(3):675-88. (PMID: 25498902) Clin Pharmacokinet. 2005;44(10):1035-50. (PMID: 16176117) Oncotarget. 2017 Dec 13;9(3):3895-3907. (PMID: 29423092) J Acquir Immune Defic Syndr. 2012 Jul 1;60 Suppl 1:S1-18. (PMID: 22688010) PLoS One. 2013;8(3):e59514. (PMID: 23533630) Clin Pharmacokinet. 2014 Oct;53(10):891-906. (PMID: 25200312) N Engl J Med. 1992 Feb 13;326(7):437-43. (PMID: 1346337) HIV AIDS (Auckl). 2013 Sep 27;5:253-62. (PMID: 24101883) J Antimicrob Chemother. 2010 Sep;65(9):1889-93. (PMID: 20639527) J Antimicrob Chemother. 2011 Feb;66(2):354-7. (PMID: 21098541) AIDS. 2017 May 15;31(8):1201-1203. (PMID: 28441180) J Pharmacol Exp Ther. 2014 Nov;351(2):250-8. (PMID: 25161171) Pharmacol Rep. 2013;65(4):937-50. (PMID: 24145088) AIDS Res Ther. 2020 Jan 7;17(1):1. (PMID: 31907064) Curr Opin HIV AIDS. 2013 May;8(3):165-9. (PMID: 23429501) Sci Rep. 2018 Apr 26;8(1):6552. (PMID: 29700323) Clin Infect Dis. 2011 Dec;53(11):1120-6. (PMID: 21998278) Toxicol Sci. 2013 Aug;134(2):323-34. (PMID: 23640862) Ann N Y Acad Sci. 1990;616:318-27. (PMID: 2078026) Annu Rev Biochem. 2016 Jun 2;85:685-713. (PMID: 26865532) J Alzheimers Dis. 2019;72(2):401-412. (PMID: 31594217) J Clin Invest. 2017 Mar 1;127(3):857-873. (PMID: 28134625) Int J Mol Med. 2013 Jun;31(6):1305-12. (PMID: 23563240) AIDS. 2012 Oct 23;26(16):2017-26. (PMID: 22948272) Autophagy. 2021 Jan;17(1):1-382. (PMID: 33634751) Annu Rev Med. 2019 Jan 27;70:137-150. (PMID: 30355266) PLoS One. 2018 Jan 19;13(1):e0191389. (PMID: 29351561) Infection. 2020 Apr;48(2):249-258. (PMID: 31893354) Arch Toxicol. 2018 Jun;92(6):2109-2118. (PMID: 29594326) Reprod Toxicol. 2014 Dec;50:122-8. (PMID: 25461911) Hepatology. 2011 Sep 2;54(3):1009-19. (PMID: 21626526) J Physiol Pharmacol. 2017 Apr;68(2):283-293. (PMID: 28614778) J Infect Dis. 2012 Jul 15;206(2):275-82. (PMID: 22551810) J Antimicrob Chemother. 2012 Feb;67(2):299-311. (PMID: 22160207) Cardiovasc Toxicol. 2016 Jan;16(1):90-9. (PMID: 25666561) Placenta. 2021 Jan 15;104:102-109. (PMID: 33310298) Cells. 2019 Sep 28;8(10):. (PMID: 31569373) Alcohol Clin Exp Res. 2015 Jan;39(1):11-20. (PMID: 25623401) AIDS. 1997 Mar 15;11(4):F29-33. (PMID: 9084785) Antiviral Res. 2019 Aug;168:36-50. (PMID: 31075350) Antiviral Res. 2016 Sep;133:178-82. (PMID: 27496003) Cells. 2020 Jun 09;9(6):. (PMID: 32526847) AIDS. 2012 Oct 23;26(16):1995-2006. (PMID: 22914580) AIDS. 2001 Jan 5;15(1):71-5. (PMID: 11192870) Lancet. 1993 Apr 3;341(8849):889-90. (PMID: 8096582) Mol Pharmacol. 2015 Aug;88(2):304-15. (PMID: 25987489) AIDS. 2019 Feb 1;33(2):259-268. (PMID: 30325781) J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):1-9. (PMID: 29847475) HIV Med. 2011 Oct;12(9):570-9. (PMID: 21569187) Autophagy. 2021 Apr;17(4):948-960. (PMID: 32186434) Clin Cancer Res. 2007 Sep 1;13(17):5183-94. (PMID: 17785575) Nanomedicine (Lond). 2018 Sep;13(17):2139-2154. (PMID: 30129397) PLoS One. 2020 Apr 30;15(4):e0231938. (PMID: 32352999) Front Cell Dev Biol. 2019 Jul 02;7:114. (PMID: 31312633) |
معلومات مُعتمدة: | T32GM00728846 United States NH NIH HHS; 5R01DA044584 United States NH NIH HHS; R01 MH112391 United States MH NIMH NIH HHS; 5R01DA048609 United States NH NIH HHS; R01 DA044584 United States DA NIDA NIH HHS; T32 GM007288 United States GM NIGMS NIH HHS; P30 AI124414 United States AI NIAID NIH HHS; T32 AI070117 United States AI NIAID NIH HHS |
فهرسة مساهمة: | Keywords: ER stress; HIV; antiretroviral drugs; autophagy; mitochondria; mitophagy; side effects; toxicity |
المشرفين على المادة: | 0 (Anti-Retroviral Agents) 0 (Protease Inhibitors) 0 (Reverse Transcriptase Inhibitors) |
تواريخ الأحداث: | Date Created: 20210430 Date Completed: 20211020 Latest Revision: 20240814 |
رمز التحديث: | 20240814 |
مُعرف محوري في PubMed: | PMC8071244 |
DOI: | 10.3390/cells10040909 |
PMID: | 33920955 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2073-4409 |
---|---|
DOI: | 10.3390/cells10040909 |